Contact Information
Company Information
Annual Revenue
11033000.0
Technologies
Outlook
Microsoft Office 365
WordPress.org
Vimeo
reCAPTCHA
Google Analytics
Mobile Friendly
Nginx
Google Tag Manager
Remote
Keywords
immunotherapy
immunooncology
neoantigens
dna vaccine
hpv16
neoepitopes
oncology
biotechnology research
biopharmaceutical
clinical-stage
vaccine technology
therapeutic cancer vaccine
cancer treatment
immune response
vaccibody platform
antigen targeting
patient-centric solutions
cancer neoantigen
roche collaboration
genentech
phase 1b trial
modular design
hyper-targeting
therapeutic areas
autoimmunity
drug development
scientific strategy
partnerships
cancer vaccines
hpv16-positive cancers
long-lasting immunity
immune system modulation
innovative therapeutics
game-changing medicine
rapid immunization
cancer immunotherapy
biotech collaborations
strategic partnerships
personalized medicine
antigen presenting cells
research & development
clinical trials
pipeline expansion
financial results
investor relations
corporate governance
risk management
technology platform
drug discovery
medical advancement
cancer research
analyzing clinical data
biotechnology
pharmaceutical innovations
immunological therapies
therapeutic modalities
patient outcomes
autoimmune diseases
vaccibody technology
therapeutic vaccines
neoantigen immunotherapy
modular immunotherapy
antigen-presenting cells
immune tolerance
r&d collaborations
patient-specific treatments
transformative medicines
market presence
biopharma collaborations
disease management
unmet medical needs
advanced technology
clinical development
patient demographics
therapeutic focus
modular platform
immune modulation
oncology market
immune activation
safety profile
disease prevention
therapeutic innovation
hospital & health care
health care
health
wellness & fitness
Get Full Contact Details
Subscribe to reveal email addresses and export contacts.
View Plans